Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
JBIO is expected to report earnings to fall 3.46% to -73 cents per share on November 16
Q3'26
Est.
$-0.73
Q2'26
Missed
by $0.11
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.33
Q3'25
Missed
by $0.23
The last earnings report on August 10 showed earnings per share of -75 cents, missing the estimate of -64 cents. With 661.13K shares outstanding, the current market capitalization sits at 912.62M.